SCHEMBL7145763

SCHEMBL7145763

CCOC(=O)CC(NS(=O)(=O)c1cccc(N)c1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
MAPT P10636 2/20 0.54
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.51
ATM Q13315 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
ITGB3 P05106 4/20 0.48
ITGAV P06756 4/20 0.48
EEF2K O00418 3/20 0.47
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
THRB P10828 1/20 0.44
POLB P06746 2/20 0.43
GRK2 P25098 1/20 0.43
DUSP3 P51452 1/20 0.43
PTPN5 P54829 1/20 0.43
PTPN11 Q06124 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PRMT1 Q99873 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7410768 0.94 ITGB3 (0.54) ALDH1A1MAPTKMT2AMEN1ATM
SCHEMBL5878081 0.94 ITGB3 (0.54) ALDH1A1MAPTKMT2AMEN1ATM
SCHEMBL3837360 0.93 ALDH1A1 (0.54) ALDH1A1MAPTKMT2AMEN1ATM
SCHEMBL3834077 0.90 ALDH1A1 (0.50) ALDH1A1MAPTKMT2AMEN1ATM
SCHEMBL3840533 0.89 ALDH1A1 (0.51) ALDH1A1MAPTKMT2AMEN1ATM
SCHEMBL6896597 0.88 MAPT (0.60) ALDH1A1MAPTKMT2AMEN1ATM
SCHEMBL6774065 0.88 ALDH1A1 (0.55) ALDH1A1MAPTKMT2AMEN1ATM
SCHEMBL5878110 0.87 ALDH1A1 (0.54) ALDH1A1MAPTKMT2AMEN1ATM
SCHEMBL7144205 0.85 EEF2K (0.64) ALDH1A1ATML3MBTL1ITGB3ITGAV
SCHEMBL7194134 0.84 MAPT (0.59) ALDH1A1MAPTKMT2AMEN1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0928790-B1 Thiazole derivatives HOFFMANN LA ROCHE (CH) 2003-03-05 EP disclosed
CN-1080720-C Thiazole derivatives HOFFMANN LA ROCHE (CH) 2002-03-13 CN disclosed
US-20020010316-A1 Thiazole derivatives ALIG LEO (CH) 2002-01-24 US disclosed
US-6320054-B1 INHIBIT BINDING OF ADHESIVE PROTEINS TO THE SURFACE OF DIFFERENT TYPES F CELL AND ACCORDINGLY INFLUENCE CELL-CELL AND CELL-MATRIX INTERACTIONS. HOFFMAN-LA ROCHE INC. 2001-11-20 US disclosed
US-6100282-A Thiazole derivatives HOFFMAN-LA ROCHE INC. (US) 2000-08-08 US disclosed
CN-1224718-A Thiazole derivatives HOFFMANN LA ROCHE (CH) 1999-08-04 CN disclosed
EP-0928790-A1 Thiazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 1999-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010316-A1 Thiazole derivatives VCAM1, SOST, TGFB1 ALDH1A1 1400/4885MAPT 86/4885KMT2A 4510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.